search
cancer treatment
Trends
- 1Missing Y chromosome pieces found to drive cancer in men●Study shows how missing pieces of Y chromosome drive cancer in men
A new study shows how loss of parts of the Y chromosome, a common age-related change in men's cells, can promote cancer growth. Researchers report the missing pieces help tumours evade immune defences, offering a possible explanation for why some cancers in men are more aggressive and opening paths to new treatments.
- 213-Year-Old Cured of DIPG, the Deadliest Childhood Brain Cancer●A 13-Year-Old Has Been Cured of DIPG, the Deadliest Childhood Brain Cancer
A 13-year-old child has reportedly been cured of DIPG, diffuse intrinsic pontine glioma, an aggressive brainstem cancer that has almost always been fatal in children. The case is being described as a world first, and it is drawing wide attention because DIPG has resisted decades of treatment efforts, with most children surviving less than a year after diagnosis. Families, researchers and clinicians are watching closely for confirmation and details of the treatment used.
- 3Scientists Watch a Deadly Cancer Physically Reshape the Brain▼Scientists Watched a Deadly Cancer Physically Reshape The Brain as It Grew
Researchers report observing how an aggressive brain cancer physically remodels brain tissue as it grows, offering a live view of tumor progression. The findings shed light on how deadly brain tumors invade and distort surrounding structures, which could inform future treatment approaches. The work is drawing attention for its striking visualization of the disease's effects on the brain.
- 4Highlights Emerge from World Cancer Congress 2026▼Highlights from World Cancer Congress 2026 – Part 2
Coverage is circulating of the second part of a highlights roundup from the World Cancer Congress 2026, summarising key presentations and developments shared at the global oncology gathering. The roundup is aimed at cancer professionals and researchers following the congress remotely, distilling sessions into digestible takeaways. Interest centres on what new research, treatment approaches and policy discussions were featured at this year's event.
- 5Penn Medicine and IBA Launch Global Proton Therapy Venture▼Penn Medicine and IBA Launch Joint Venture to Advance Proton Therapy and Radiation Oncology Program Development Worldwide
Penn Medicine and Belgian proton therapy company IBA have announced a joint venture to support the development of proton therapy and radiation oncology programs worldwide. The partnership aims to help hospitals and clinics internationally establish and expand advanced cancer treatment services, combining Penn Medicine's clinical expertise with IBA's technology. The announcement has been picked up by financial and international news outlets.
- 6Physicists help explain how tumor DNA loops drive cancer▼Theoretical physics helps uncover the molecular mechanisms of extrachromosomal DNA in tumors
Researchers at the University of Naples Federico II report that theoretical physics methods have helped reveal the molecular mechanisms governing extrachromosomal DNA in tumors. These circular DNA fragments, separate from chromosomes, are known to promote cancer growth and drug resistance. The study applies physical modelling to understand their behavior, potentially opening new avenues for cancer research and treatment strategies.
- 7IBA and Penn Medicine Launch Noventra Oncology Alliance▼IBA, Penn Medicine Announce Noventra Oncology Alliance Joint Venture
IBA and Penn Medicine have announced a joint venture called the Noventra Oncology Alliance, combining the particle therapy technology company's expertise with the academic medical center's clinical and research capabilities. The partnership is aimed at advancing cancer treatment, though further details about its scope, funding and first projects have not yet been made widely available.
- 8
Researchers report that biological features of prostate tumours can help determine which patients are most likely to benefit from hormone therapy. By profiling tumour biology, doctors may be able to better target treatment and avoid giving hormone therapy to those unlikely to respond, a step toward more personalised prostate cancer care.
- 9Experts Highlight Technology's Role in Advancing Cancer Care●Experts Highlight Technology’s Role in Advancing Cancer Care
Experts say technology is playing a growing role in advancing cancer care, pointing to improvements in diagnosis, treatment planning and patient outcomes. The discussion reflects wider attention on how digital tools and medical innovation are reshaping oncology practice. Little detail is available beyond the headline, so the specific technologies and experts involved remain unclear.
- 10Eric Deutsch on the Fast-Growing Science Linking Radiation Oncology and Immunology▼Eric Deutsch: The Science Is Expanding Fast at the Interface of Radiation Oncology, Immunology, and Technology
Radiation oncology expert Eric Deutsch says science is expanding rapidly at the intersection of radiation therapy, immunology, and technology, as combined approaches such as radiotherapy paired with immunotherapy gain ground in cancer treatment. His remarks highlight how technological advances and immune-based research are reshaping how clinicians think about radiation's role beyond tumour destruction.